Farnoosh et al. found that supplementation of patients hospitalized for COVID-19 with low-dose oral melatonin (3 mg 3 times/day) significantly improved their symptoms (coughing, dyspnea, and fatigue) and reduced their CRP levels in comparison to controls receiving the standard treatment alone. Here, CRP is linked to COVID-19.